Literatur
Cursiefen C, Küchle M, Naumann GOH (1998) Changing indications for penetrating keratoplasty: histopathology of 1250 corneal buttons. Cornea 17: 468–470
Spoerl E, Huhle M, Seiler T (1998) Induction of cross-links in corneal tissue. Exp Eye Res 66: 97–103
Koller T, Seiler T (2007) Therapeutic cross-linking of the cornea using riboflavin/UVA. Klin Monatsbl Augenheilkd 224: 700–706
Wollensak G, Spoerl E, Seiler T (2003) Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135: 620–627
Wollensak G (2006) Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol 17: 356–360
Hoyer A, Raiskup-Wolf F, Spörl E, Pillunat LE (in Druck) Kollagenvernetzung mit Riboflavin und UVA-Licht bei Keratokonus – Dresdner Ergebnisse. Ophthalmologe
Davis LJ, Schechtman KB, Wilson BS et al. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group (2006) Longitudinal changes in visual acuity in keratoconus. Invest Ophthalmol Vis Sci 47: 489–500
Barr JT, Wilson BS, Gordon MO et al. CLEK Study Group (2006) Estimation of the incidence and factors predictive of corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Cornea 25: 16–25
Wollensak G, Spörl E, Reber F et al. (2003) Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro. Ophthalmic Res 35: 324–328
Interessenkonflikt
Keine Angaben.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cursiefen, C. Korneales Crosslinking: „Sicher und effektiv?“. Ophthalmologe 106, 164–166 (2009). https://doi.org/10.1007/s00347-008-1790-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-008-1790-3